294 related articles for article (PubMed ID: 28967699)
1. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.
Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M
ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699
[TBL] [Abstract][Full Text] [Related]
2. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.
Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM
J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181
[TBL] [Abstract][Full Text] [Related]
3. Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function.
Onitsuka H; Koyama S; Ideguchi T; Ishikawa T; Kitamura K; Nagamachi S
Medicine (Baltimore); 2019 Feb; 98(8):e14657. PubMed ID: 30813209
[TBL] [Abstract][Full Text] [Related]
4. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry.
Kapelios CJ; Laroche C; Crespo-Leiro MG; Anker SD; Coats AJS; Díaz-Molina B; Filippatos G; Lainscak M; Maggioni AP; McDonagh T; Mebazaa A; Metra M; Moura B; Mullens W; Piepoli MF; Rosano GMC; Ruschitzka F; Seferovic PM; Lund LH;
Eur J Heart Fail; 2020 Aug; 22(8):1424-1437. PubMed ID: 32237110
[TBL] [Abstract][Full Text] [Related]
5. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
[TBL] [Abstract][Full Text] [Related]
6. Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.
Woodruff AE; Kelley AM; Hempel CA; Loeffler WJ; Echtenkamp CA; Hassan AK
Ann Pharmacother; 2016 Jun; 50(6):437-45. PubMed ID: 26956954
[TBL] [Abstract][Full Text] [Related]
7. Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION.
Fudim M; O'Connor CM; Mulder H; Coles A; Bhatt AS; Ambrosy AP; Kraus WE; Piña IL; Whellan DJ; Mentz RJ
Am Heart J; 2018 Nov; 205():133-141. PubMed ID: 30158057
[TBL] [Abstract][Full Text] [Related]
8. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.
Ter Maaten JM; Martens P; Damman K; Dickstein K; Ponikowski P; Lang CC; Ng LL; Anker SD; Samani NJ; Filippatos G; Cleland JG; Zannad F; Hillege HL; van Veldhuisen DJ; Metra M; Voors AA; Mullens W
Clin Res Cardiol; 2020 Aug; 109(8):1048-1059. PubMed ID: 32002631
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
[TBL] [Abstract][Full Text] [Related]
10. The effects of tolvaptan dose on cardiac mortality in patients with acute decompensated heart failure after hospital discharge.
Matsumoto K; Ehara S; Nakamura Y; Otsuka K; Kawase Y
Heart Vessels; 2018 Oct; 33(10):1204-1213. PubMed ID: 29687159
[TBL] [Abstract][Full Text] [Related]
11. Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis.
Yilmaz MB; Gayat E; Salem R; Lassus J; Nikolaou M; Laribi S; Parissis J; Follath F; Peacock WF; Mebazaa A
Eur J Heart Fail; 2011 Nov; 13(11):1244-52. PubMed ID: 22024466
[TBL] [Abstract][Full Text] [Related]
12. Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD).
Hamaguchi S; Kinugawa S; Tsuchihashi-Makaya M; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
Circ J; 2012; 76(8):1920-7. PubMed ID: 22665070
[TBL] [Abstract][Full Text] [Related]
13. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
[TBL] [Abstract][Full Text] [Related]
15. Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
Damman K; Kjekshus J; Wikstrand J; Cleland JG; Komajda M; Wedel H; Waagstein F; McMurray JJ
Eur J Heart Fail; 2016 Mar; 18(3):328-36. PubMed ID: 26693947
[TBL] [Abstract][Full Text] [Related]
16. Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
Mentz RJ; Hasselblad V; DeVore AD; Metra M; Voors AA; Armstrong PW; Ezekowitz JA; Tang WH; Schulte PJ; Anstrom KJ; Hernandez AF; Velazquez EJ; O'Connor CM
Am J Cardiol; 2016 Feb; 117(3):404-11. PubMed ID: 26704029
[TBL] [Abstract][Full Text] [Related]
17. Observation of Patients Transitioned to an Oral Loop Diuretic Before Discharge and Risk of Readmission for Acute Decompensated Heart Failure.
Laliberte B; Reed BN; Devabhakthuni S; Watson K; Ivaturi V; Liu T; Gottlieb SS
J Card Fail; 2017 Oct; 23(10):746-752. PubMed ID: 28688888
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Discharged Loop Diuretic Dose to Home Dose on Hospital Readmissions in Patients with Acute Decompensated Heart Failure: A Retrospective Cohort Study.
Alshibani M; Alshehri S; Alyazidi W; Alnomani A; Almatruk Z; Almeleebia T
Heart Surg Forum; 2020 Jul; 23(4):E470-E474. PubMed ID: 32726210
[TBL] [Abstract][Full Text] [Related]
19. Tolvaptan Improves Prognosis in Responders with Acute Decompensated Heart Failure by Reducing the Dose of Loop Diuretics.
Nakamura M; Sunagawa O; Kinugawa K
Int Heart J; 2018; 59(1):87-93. PubMed ID: 29375117
[TBL] [Abstract][Full Text] [Related]
20. Loop diuretic down-titration at discharge in patients hospitalized for acute heart failure.
Croset F; Llàcer P; Núñez J; Campos J; García M; Pérez A; Fernández C; Fabregate M; López G; Tello S; Fernández JM; Ruiz R; Manzano L
ESC Heart Fail; 2024 Jun; 11(3):1739-1747. PubMed ID: 38454739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
